Actively Recruiting
ANDREAS Registry Monitoring Long-Term Outcomes of Drug-Coated Balloon Use in Adults Undergoing PCI for New Coronary Artery Disease
Led by Emory University · Updated on 2026-10-05
5000
Participants Needed
19
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a prospective, international, multicenter registry to collect long-term clinical data on adult patients undergoing percutaneous coronary intervention PCI with drug-coated balloons DCB for new coronary artery disease. The goal is to evaluate outcomes such as safety and effectiveness of DCB in this population. Emory University coordinates the data collection through a centralized database. Participants receive standard medical care without any experimental interventions mandated by the study. The choice of drug-coated balloon, vessel preparation, and additional medications are decided by the treating physician. Data are collected during routine clinical care and entered into a secure database by participating centers. Participants are followed over time with assessments at hospital discharge, 30 days, 6 months, 12 months, and annually up to 5 years after discharge. Researchers monitor key outcomes including target lesion failure, mortality, myocardial infarction, repeat revascularization, vessel failure, thrombosis, and bleeding events. This long-term follow-up provides valuable information about the clinical performance of DCB therapy.
CONDITIONS
Brief Title
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)
Research Team
D
Daniel Gold, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here